SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Regeneron Pharmaceuticals
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
3557 104 0 REGN
Emcee:  Patrick Slevin Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2832On another topic regn Mers phase1 got removed from latest presentation. Any idBiotechwantabe-1/23/2020
2831telegraph.co.uk Any option on this immune cell.Biotechwantabe-1/23/2020
2830Now, all they need is REGN-China, and none would be more happy than me! :-(Miljenko Zuanic-1/13/2020
2829News from JPM20....regn is building marketing infrastructure in ex-US territorieMiljenko Zuanic-1/13/2020
2828I replied in: investorshub.advfn.comDewDiligence_on_SI-1/6/2020
2827RE: Keytruda in extensive stage SCLC; investors.merck.com there was also an iMiljenko Zuanic-1/6/2020
2826Marry Christmas to all! For those that practice other faith than Christianity, mMiljenko Zuanic112/23/2019
2825Interesting CMS data for Eylea/Lucentis for 2018, relative to 2017. Eylea...spMiljenko Zuanic212/19/2019
2824CMS dashboard drug spending for 2018, part B and Part D: portal.cms.govMiljenko Zuanic-12/19/2019
2823I think they had a choice between Evercore and P. Jaffray, they chose Jaffray whMiljenko Zuanic112/17/2019
2822I do not. I read it from someone who posted snippet on twitter. How did you CuttingEdge Bio-12/16/2019
2821Do you have full report, to see who those MDs are, what were the Qs and what As?Miljenko Zuanic-12/16/2019
2820This doesn't sound good from Evercore downgrade Schimmer talked to high volCuttingEdge Bio-12/16/2019
2819Thanks. Most intriguing is asthma, +2M WW subjects eligible...at $25K/Y averageMiljenko Zuanic-12/12/2019
2818Not market /peak sales projectionBiotechwantabe-12/12/2019
2817sanofi.com Additionally info on dupixent market. Justify the 11B market.Biotechwantabe-12/12/2019
2816It is new, conduced by Sanofi (International, US included). primary: Rate of modMiljenko Zuanic-12/11/2019
2815Is this on top of asthma data or old? If former than program likely dead, if noFelix B-12/11/2019
2814Few more details from Sanofi Capitals Market... sanofi.com anti-IL-33 Ab failedMiljenko Zuanic-12/9/2019
2813Sanofi further to restructure, plan to START selling its interest (23M shares toMiljenko Zuanic-12/9/2019
2812Maybe. But, there is promise in THOR unnatural AA technology...IF one knows how Miljenko Zuanic-12/9/2019
2811SNY seems to be paying a lot for THOR's unproven technology. They clearly waDewDiligence_on_SI-12/9/2019
2810ASH presentation and THOR IL-2 mimetic...(sanovi latest launch) investor.regenerMiljenko Zuanic-12/9/2019
2809RE: OT, AD XBIT sold bermekimab (at P2) to Janssen, for $1.3B (assuming all cliMiljenko Zuanic-12/7/2019
2808Bros buying 25% of share offering + $25M (so ~$90M total), well that will put thMiljenko Zuanic-12/2/2019
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News